Stefan Reinelt

Title: The Innovative Contributions of Stefan Reinelt

Introduction

Stefan Reinelt is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His work exemplifies the intersection of innovation and medical research.

Latest Patents

Reinelt holds a patent for "Benzo[h]quinazolin-4-amine and thieno[3,2-h]quinazolin-4-amine derivatives for the treatment of cancer." This invention provides compounds of formula (IA) and compounds of formula (IB), along with pharmaceutically acceptable salts. The compounds are designed to treat neoplastic diseases, especially cancer, by utilizing specific chemical structures and methods outlined in the patent.

Career Highlights

Stefan Reinelt is associated with Redona Therapeutics, Inc., where he continues to advance his research and development efforts. His work has led to the creation of innovative solutions aimed at combating cancer, showcasing his dedication to improving patient outcomes through scientific discovery.

Collaborations

Reinelt collaborates with talented professionals in his field, including Bérangère Gaucher and Florian Richalet. These partnerships enhance the research environment and contribute to the successful development of new therapeutic approaches.

Conclusion

Stefan Reinelt's contributions to cancer treatment through his innovative patents and collaborative efforts highlight the importance of research in the pharmaceutical industry. His work continues to inspire advancements in medical science and offers hope for improved therapies for cancer patients.